Kari Hinds

Kari Hinds, PMP, currently serves as the Director of Program Management and Operational Excellence-Disease Area Strategy Leader at Daiichi Sankyo US since October 2023. Previously, Kari held the position of Senior Director of Program Management at Immunovant from July 2022 to August 2023, and participated as a CEO Action for Racial Equity Fellow at Horizon from March 2021 to July 2022, focusing on public policies and corporate strategies to combat systemic racism. Additional experience includes roles such as Director of Program and Project Management at Viela Bio, Director of Program and Portfolio Management at AstraZeneca, and various positions at Otsuka Pharmaceutical Companies and Cardiocore Labs. Kari's educational background includes a Master's of Science in Biotechnology from The Johns Hopkins University and a Bachelor's of Science in Biochemistry from Claflin University.